Morphic (NASDAQ: MORF)
Some price data may be temporarily unavailable.
Morphic Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Morphic Company Info
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
News & Analysis
Featured Article
Is Morphic Holding a Buy?
This experimental biotech has more than tripled investors' money over the past 12 months.
Zhiyuan Sun | Apr 14, 2021
Featured Article
Why Morphic Holding Stock Is Falling Today
The company announced a proposed public offering of common stock.
Prosper Junior Bakiny | Mar 2, 2021
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.